These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16272095)

  • 21. The emerging role of microRNAs in immune cell development and differentiation.
    Liang TJ; Qin CY
    APMIS; 2009 Sep; 117(9):635-43. PubMed ID: 19703123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs as oncogenes and tumor suppressors.
    Chen CZ
    N Engl J Med; 2005 Oct; 353(17):1768-71. PubMed ID: 16251533
    [No Abstract]   [Full Text] [Related]  

  • 23. All you need is a Mir-acle: the role of nontranslated RNAs in the suppression of B cell chronic lymphocytic leukemia.
    Lichter P
    Cancer Cell; 2010 Jan; 17(1):3-4. PubMed ID: 20129242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The c-myc promoter: still MysterY and challenge.
    Wierstra I; Alves J
    Adv Cancer Res; 2008; 99():113-333. PubMed ID: 18037408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of expression of the c-myc proto-oncogene.
    Marcu KB
    Bioessays; 1987 Jan; 6(1):28-32. PubMed ID: 3551944
    [No Abstract]   [Full Text] [Related]  

  • 26. RNA interference: MicroRNAs as biomarkers.
    Baker M
    Nature; 2010 Apr; 464(7292):1227. PubMed ID: 20414310
    [No Abstract]   [Full Text] [Related]  

  • 27. Where is the biology of CLL leading us?
    Caligaris-Cappio F; Chiorazzi N
    Semin Cancer Biol; 2010 Dec; 20(6):361-2. PubMed ID: 21130365
    [No Abstract]   [Full Text] [Related]  

  • 28. MicroRNAs and cancer-the search begins!
    Oulas A; Reczko M; Poirazi P
    IEEE Trans Inf Technol Biomed; 2009 Jan; 13(1):67-77. PubMed ID: 19129025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs: novel regulators in the hallmarks of human cancer.
    Ruan K; Fang X; Ouyang G
    Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Apoptosis and cancer].
    Duhem C; Ries F; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1994; 131(1):39-48. PubMed ID: 8050118
    [No Abstract]   [Full Text] [Related]  

  • 31. MicroRNAs in clinical oncology: at the crossroads between promises and problems.
    Metias SM; Lianidou E; Yousef GM
    J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Involvement of microRNAs in cancer biology and possibilities of their application to diagnostic and predictive oncology].
    Slabý O; Krekác D; Hrstka R; Svoboda M; Vyzula R
    Cas Lek Cesk; 2008; 147(1):25-31. PubMed ID: 18323039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
    Spandidos DA
    J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct patterns in the regulation and evolution of human cancer genes.
    Furney SJ; Madden SF; Kisiel TA; Higgins DG; Lopez-Bigas N
    In Silico Biol; 2008; 8(1):33-46. PubMed ID: 18430988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [RNA and cancer].
    Jeanteur P
    Bull Cancer; 2008 Jan; 95(1):33-41. PubMed ID: 18230568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer genomics: the unknown unknowns.
    Lotze MT; Yu Y
    Curr Opin Investig Drugs; 2006 Jun; 7(6):497-500. PubMed ID: 16784019
    [No Abstract]   [Full Text] [Related]  

  • 37. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA; Craig FE; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs: small but potent oncogenes or tumor suppressors.
    Lee YS; Dutta A
    Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic enzymes regulated by the Myc oncogene are possible targets for chemotherapy or chemoprevention.
    Rimpi S; Nilsson JA
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):305-10. PubMed ID: 17371266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer biology: signatures guide drug choice.
    Downward J
    Nature; 2006 Jan; 439(7074):274-5. PubMed ID: 16421553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.